JP2010535790A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010535790A5 JP2010535790A5 JP2010520238A JP2010520238A JP2010535790A5 JP 2010535790 A5 JP2010535790 A5 JP 2010535790A5 JP 2010520238 A JP2010520238 A JP 2010520238A JP 2010520238 A JP2010520238 A JP 2010520238A JP 2010535790 A5 JP2010535790 A5 JP 2010535790A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- serotonin reuptake
- selective serotonin
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95369407P | 2007-08-03 | 2007-08-03 | |
| US60/953,694 | 2007-08-03 | ||
| PCT/US2008/072066 WO2009020897A1 (en) | 2007-08-03 | 2008-08-04 | Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine recptor ligands |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010535790A JP2010535790A (ja) | 2010-11-25 |
| JP2010535790A5 true JP2010535790A5 (OSRAM) | 2011-09-22 |
| JP5460594B2 JP5460594B2 (ja) | 2014-04-02 |
Family
ID=40338740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010520238A Active JP5460594B2 (ja) | 2007-08-03 | 2008-08-04 | ドーパミン受容体リガンドを含有する医薬組成物およびドーパミン受容体リガンドを用いる処置方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US20090036468A1 (OSRAM) |
| EP (1) | EP2185155B1 (OSRAM) |
| JP (1) | JP5460594B2 (OSRAM) |
| KR (1) | KR101612563B1 (OSRAM) |
| CN (1) | CN101815519B (OSRAM) |
| AU (1) | AU2008283989B2 (OSRAM) |
| CA (1) | CA2695519A1 (OSRAM) |
| CY (1) | CY1119828T1 (OSRAM) |
| DK (1) | DK2185155T3 (OSRAM) |
| EA (1) | EA018064B1 (OSRAM) |
| ES (1) | ES2653852T3 (OSRAM) |
| HR (1) | HRP20171908T1 (OSRAM) |
| HU (1) | HUE036004T2 (OSRAM) |
| LT (1) | LT2185155T (OSRAM) |
| MY (1) | MY157192A (OSRAM) |
| NO (1) | NO2185155T3 (OSRAM) |
| PL (1) | PL2185155T3 (OSRAM) |
| PT (1) | PT2185155T (OSRAM) |
| SI (1) | SI2185155T1 (OSRAM) |
| WO (1) | WO2009020897A1 (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ590852A (en) | 2008-07-16 | 2013-03-28 | Richter Gedeon Nyrt | Pharmaceutical formulations containing dopamine receptor ligands trans-1{ 4-[2-[4-(2,3-dichlorophenyl)-piperizin-1-yl]-ethyl]-cyclohexyl} -3,3-dimethyl-urea also known as cariprazine |
| US20110117214A1 (en) * | 2009-11-16 | 2011-05-19 | Auspex Pharmaceuticals, Inc. | Cyclohexyl urea modulators of d2 receptors and/or d3 receptors |
| HUE031556T2 (en) * | 2010-06-18 | 2017-07-28 | Altos Therapeutics Llc | D2 antagonists, methods of synthesis and methods of use |
| WO2014031162A1 (en) | 2012-08-20 | 2014-02-27 | Forest Laboratories Holdings Limited | Crystalline form of carbamoyl-cyclohexane derivatives |
| US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
| HUP1700253A1 (hu) * | 2017-06-13 | 2019-01-28 | Richter Gedeon Nyrt | Szilárd orális gyógyszerkészítmények |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| HU231500B1 (hu) * | 2019-04-10 | 2024-04-28 | Richter Gedeon Nyrt | Karbamoil-ciklohexán származékok autizmus spektrum betegség kezelésére |
| US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
| AU2020258086A1 (en) | 2019-04-17 | 2021-11-11 | Compass Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
| US20230149392A1 (en) * | 2021-10-28 | 2023-05-18 | Abbvie Inc. | Treatment of major depressive disorder |
| JP2025500844A (ja) * | 2021-12-13 | 2025-01-15 | コンパス パスファインダー リミテッド | 治療抵抗性うつ病の治療に使用するためのサイロシビン及び補助的セロトニン再取り込み阻害剤 |
| CN119136804A (zh) * | 2022-03-17 | 2024-12-13 | Mapi医药公司 | 包含卡利拉嗪或其盐的储库系统 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
| ZA977967B (en) * | 1996-09-23 | 1999-03-04 | Lilly Co Eli | Combination therapy for treatment of psychoses |
| US6960577B2 (en) * | 1998-05-22 | 2005-11-01 | Eli Lilly And Company | Combination therapy for treatment of refractory depression |
| US6556540B1 (en) * | 1998-05-29 | 2003-04-29 | Paradyne Corporation | System and method for non-intrusive measurement of service quality in a communications network |
| HRP20020344B1 (hr) * | 1999-10-25 | 2010-10-31 | H. Lundbeck A/S | Način priprave citaloprama |
| UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
| YU85303A (sh) * | 2001-05-01 | 2006-05-25 | H. Lundbeck A/S | Upotreba enantiomerno čistog escitaloprama |
| US7030122B2 (en) * | 2002-04-12 | 2006-04-18 | Sepracor Inc. | 1,4-disubstituted piperazine ligands for neurotransmitter receptors |
| DE60312874T2 (de) * | 2002-06-20 | 2008-01-17 | H. Lundbeck A/S | Kombinationstherapie mit verwendung eines serotonin-wiederaufnahmehemmers |
| HU227534B1 (en) * | 2003-08-04 | 2011-08-29 | Richter Gedeon Nyrt | (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them |
| US20070042014A1 (en) * | 2003-09-04 | 2007-02-22 | H. Lundbeck A/S | Combination of a serotonin reuptake inhibitor and loxapine |
| HUP0500170A3 (en) * | 2005-02-03 | 2007-11-28 | Richter Gedeon Nyrt | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them |
| TW200812993A (en) * | 2006-05-02 | 2008-03-16 | Lundbeck & Co As H | New uses of escitalopram |
| HU230748B1 (hu) * | 2007-05-11 | 2018-02-28 | Richter Gedeon Nyrt | Új piperazin só és előállítási eljárása |
-
2008
- 2008-08-04 NO NO08782602A patent/NO2185155T3/no unknown
- 2008-08-04 US US12/185,211 patent/US20090036468A1/en not_active Abandoned
- 2008-08-04 HU HUE08782602A patent/HUE036004T2/hu unknown
- 2008-08-04 CA CA2695519A patent/CA2695519A1/en not_active Abandoned
- 2008-08-04 CN CN2008801062563A patent/CN101815519B/zh active Active
- 2008-08-04 ES ES08782602.0T patent/ES2653852T3/es active Active
- 2008-08-04 KR KR1020107004638A patent/KR101612563B1/ko active Active
- 2008-08-04 AU AU2008283989A patent/AU2008283989B2/en active Active
- 2008-08-04 JP JP2010520238A patent/JP5460594B2/ja active Active
- 2008-08-04 EP EP08782602.0A patent/EP2185155B1/en active Active
- 2008-08-04 LT LTEP08782602.0T patent/LT2185155T/lt unknown
- 2008-08-04 DK DK08782602.0T patent/DK2185155T3/en active
- 2008-08-04 PT PT87826020T patent/PT2185155T/pt unknown
- 2008-08-04 MY MYPI2010000523A patent/MY157192A/en unknown
- 2008-08-04 HR HRP20171908TT patent/HRP20171908T1/hr unknown
- 2008-08-04 EA EA201000280A patent/EA018064B1/ru unknown
- 2008-08-04 PL PL08782602T patent/PL2185155T3/pl unknown
- 2008-08-04 WO PCT/US2008/072066 patent/WO2009020897A1/en not_active Ceased
- 2008-08-04 SI SI200831900T patent/SI2185155T1/en unknown
-
2010
- 2010-09-27 US US12/890,752 patent/US20110015208A1/en not_active Abandoned
-
2011
- 2011-10-10 US US13/269,928 patent/US20120028991A1/en not_active Abandoned
-
2017
- 2017-12-07 CY CY20171101293T patent/CY1119828T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010535790A5 (OSRAM) | ||
| JP2012521428A5 (OSRAM) | ||
| US9988390B2 (en) | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease | |
| JP2010527985A5 (OSRAM) | ||
| CA2969557A1 (en) | Sulfide alkyl and pyridyl reverse sulfonamide compounds for hbv treatment | |
| JP4751567B2 (ja) | 新規アミド誘導体およびその医薬としての用途 | |
| JP2012521429A5 (OSRAM) | ||
| JP2010527984A5 (OSRAM) | ||
| JP2015524457A (ja) | ジヒドロキシピリミジン炭酸誘導体及びウイルス性疾患の治療、改善又は予防における使用 | |
| JP2008001718A5 (OSRAM) | ||
| JP2016518305A5 (OSRAM) | ||
| JP2007500720A5 (OSRAM) | ||
| JP2010509356A5 (OSRAM) | ||
| JP2015509535A5 (OSRAM) | ||
| JP2005529926A5 (OSRAM) | ||
| JP2011518811A5 (OSRAM) | ||
| JP2002508364A5 (OSRAM) | ||
| JP2011529502A5 (OSRAM) | ||
| JP2016508145A5 (OSRAM) | ||
| RU2012108423A (ru) | Ацилгуанидиновые производные с азотсодержащим циклом | |
| JP2020111571A5 (OSRAM) | ||
| JP2008525400A5 (OSRAM) | ||
| JP2011524898A5 (OSRAM) | ||
| JPWO2022145408A5 (OSRAM) | ||
| JP2009541261A5 (OSRAM) |